Simplex Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-129,600
| Closed | -$393K | – | 10007 |
|
|
2024
Q4 | $393K | Buy |
129,600
+82,600
| +176% | +$360K | ﹤0.01% | 3797 |
|
|
2024
Q3 | $243K | Sell |
47,000
-35,000
| -43% | -$174K | ﹤0.01% | 4327 |
|
|
2024
Q2 | $210K | Buy |
82,000
+5,800
| +8% | +$19.8K | ﹤0.01% | 4604 |
|
|
2024
Q1 | $374K | Buy |
76,200
+18,600
| +32% | +$110K | ﹤0.01% | 4150 |
|
|
2023
Q4 | $506K | Buy |
57,600
+15,600
| +37% | +$128K | ﹤0.01% | 3691 |
|
|
2023
Q3 | $481K | Buy |
42,000
+25,700
| +158% | +$494K | ﹤0.01% | 3444 |
|
|
2023
Q2 | $412K | Buy |
16,300
+1,100
| +7% | +$34.3K | ﹤0.01% | 3515 |
|
|
2023
Q1 | $489K | Sell |
15,200
-30,400
| -67% | -$948K | ﹤0.01% | 3289 |
|
|
2022
Q4 | $841K | Sell |
45,600
-22,500
| -33% | -$515K | ﹤0.01% | 2645 |
|
|
2022
Q3 | $1.84M | Buy |
68,100
+26,900
| +65% | +$546K | ﹤0.01% | 2039 |
|
|
2022
Q2 | $569K | Sell |
41,200
-47,800
| -54% | -$736K | ﹤0.01% | 3287 |
|
|
2022
Q1 | $1.74M | Buy |
89,000
+77,400
| +667% | +$1.17M | ﹤0.01% | 2254 |
|
|
2021
Q4 | $189K | Buy |
11,600
+10,800
| +1,350% | +$180K | ﹤0.01% | 5286 |
|
|
2021
Q3 | $24K | Buy |
800
+100
| +14% | +$2.85K | ﹤0.01% | 8294 |
|
|
2021
Q2 | $20K | Buy |
700
+688
| +5,733% | +$19.8K | ﹤0.01% | 8602 |
|
|
2021
Q1 | $33K | Sell |
12
-122
| -91% | -$3.37K | ﹤0.01% | 7049 |
|
|
2020
Q4 | $379K | Buy |
134
+98
| +272% | +$2.54K | ﹤0.01% | 3793 |
|
|
2020
Q3 | $90K | Buy |
36
+6
| +20% | +$157 | ﹤0.01% | 5026 |
|
|
2020
Q2 | $73K | Sell |
30
-3
| -9% | -$59 | ﹤0.01% | 5135 |
|
|
2020
Q1 | $48K | Sell |
33
-84
| -72% | -$1.74K | ﹤0.01% | 5175 |
|
|
2019
Q4 | $189K | Buy |
117
+13
| +13% | +$202 | ﹤0.01% | 3832 |
|
|
2019
Q3 | $135K | Hold |
104
| – | – | ﹤0.01% | 3982 |
|
|
2019
Q2 | $134K | Buy |
104
+84
| +420% | +$1.06K | ﹤0.01% | 3889 |
|
|
2019
Q1 | $31K | Buy |
+20
| New | +$347 | ﹤0.01% | 5397 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | -$14K | – | 7974 |
|
|
2018
Q3 | $14K | Sell |
6
-7
| -54% | -$190 | ﹤0.01% | 6246 |
|
|
2018
Q2 | $35K | Sell |
13
-15
| -54% | -$451 | ﹤0.01% | 5420 |
|
|
2018
Q1 | $4K | Buy |
28
+2
| +8% | +$64 | ﹤0.01% | 4863 |
|
|
2017
Q4 | $1K | Buy |
+26
| New | +$747 | ﹤0.01% | 5679 |
|
|
2016
Q3 | – | Sell |
-43
| Closed | -$5K | – | 6587 |
|
|
2016
Q2 | $5K | Buy |
+43
| New | +$760 | ﹤0.01% | 4295 |
|
|
2016
Q1 | – | Sell |
-81
| Closed | -$101K | – | 6394 |
|
|
2015
Q4 | $101K | Buy |
81
+79
| +3,950% | +$2.74K | 0.01% | 1357 |
|
|
2015
Q3 | $3K | Buy |
+2
| New | +$61 | ﹤0.01% | 4444 |
|
Other funds holding RVNC
Simplex Trading's RVNC Position: Q1 2025 in Review
Simplex Trading sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 38,598 shares — an estimated $117K sold.
Simplex Trading first reported a position in RVNC in Q3 2015 and held it in 25 quarters. The position peaked at $1.28M in Q3 2022. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- Simplex Trading reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 38,598 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $117K.
- Simplex Trading first reported a position in Revance Therapeutics, Inc. in Q3 2015 and held it in 25 quarters.
- Simplex Trading's Revance Therapeutics, Inc. position peaked at $1.28M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.